Jupiter Neurosciences Inc (JUNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 19 | 0 | 0 | 0 | 0 |
| Cost of Goods | 4 | N/A | N/A | N/A | N/A |
| Gross Profit | 14 | N/A | N/A | N/A | N/A |
| Operating Expenses | 1,982 | 2,831 | 2,297 | 2,265 | 1,538 |
| Operating Income | -1,963 | -2,809 | -2,297 | -2,265 | -1,538 |
| Interest Expense | 119 | 63 | 1 | 1 | 1 |
| Other Income | 20 | 296 | 10 | 13 | 10 |
| Pre-tax Income | -2,062 | -2,575 | -2,288 | -2,253 | -1,529 |
| Net Income Continuous | -2,062 | -2,575 | -2,288 | -2,253 | -1,529 |
| Net Income | $-2,062 | $-2,575 | $-2,288 | $-2,253 | $-1,529 |
| EPS Basic Total Ops | -0.06 | -0.06 | -0.07 | -0.07 | -0.05 |
| EPS Basic Continuous Ops | -0.06 | -0.07 | -0.07 | -0.07 | -0.05 |
| EPS Diluted Total Ops | -0.06 | -0.06 | -0.07 | -0.07 | -0.05 |
| EPS Diluted Continuous Ops | -0.06 | -0.07 | -0.07 | -0.07 | -0.05 |
| EPS Diluted Before Non-Recurring Items | -0.06 | -0.07 | -0.07 | -0.07 | -0.05 |
| EBITDA(a) | $-1,963 | $-2,831 | $-2,297 | $-2,265 | $-1,538 |